HRSA's Maternal and Child Health Bureau (MCHB) has selected 10 winners from Phase 1 of the Addressing Opioid Use Disorder in Pregnant Women and New Moms Challenge.
Each Phase 1 winner was awarded a share of $100,000 and will move on to Phase 2 to develop their prototype and begin small-scale testing through July 2019.
The winning innovations are technology-based solutions designed to improve access to quality health care, including substance use disorder treatment, recovery, and support services for pregnant women with opioid use disorders, their infants, and families, especially those in rural and geographically isolated areas.
Represent a broad geographic distribution
Utilize varying methodologies
Target different populations
Engage diverse partnerships
Engage other HRSA investments and recipients
The list below is ordered alphabetically by winner's name/entity.